95 related articles for article (PubMed ID: 36131941)
1. The importance of CXCR4 expression in tumor stroma as a potential biomarker in pancreatic cancer.
Bodoque-Villar R; Padilla-Valverde D; González-López LM; Muñoz-Rodríguez JR; Arias-Pardilla J; Villar-Rodríguez C; Gómez-Romero FJ; Verdugo-Moreno G; Redondo-Calvo FJ; Serrano-Oviedo L
World J Surg Oncol; 2023 Sep; 21(1):287. PubMed ID: 37697316
[TBL] [Abstract][Full Text] [Related]
2. An integrated analysis identifies six molecular subtypes of pancreatic ductal adenocarcinoma revealing cellular and molecular landscape.
Li L; Shen L; Wu H; Li M; Chen L; Zhou Q; Ma J; Huai C; Zhou W; Wei M; Zhao M; Zhao X; Du H; Jiang B; Sun Y; Zhang N; Qin S; Xing T
Carcinogenesis; 2023 Dec; 44(10-11):726-740. PubMed ID: 37747815
[TBL] [Abstract][Full Text] [Related]
3. Long-lived pancreatic ductal adenocarcinoma slice cultures enable precise study of the immune microenvironment.
Jiang X; Seo YD; Chang JH; Coveler A; Nigjeh EN; Pan S; Jalikis F; Yeung RS; Crispe IN; Pillarisetty VG
Oncoimmunology; 2017; 6(7):e1333210. PubMed ID: 28811976
[TBL] [Abstract][Full Text] [Related]
4. Cytokines and Prognostic Factors in Epithelial Ovarian Cancer.
Jammal MP; Martins-Filho A; Silveira TP; Murta EF; Nomelini RS
Clin Med Insights Oncol; 2016; 10():71-6. PubMed ID: 27512342
[TBL] [Abstract][Full Text] [Related]
5. Besieging the Tumoral Sites: Could It Be an Alternative Therapeutic Strategy in Ductal Pancreatic Adenocarcinoma?
Delma MI
Cureus; 2020 Oct; 12(10):e10909. PubMed ID: 33194476
[TBL] [Abstract][Full Text] [Related]
6. Deconstructing tumor heterogeneity: the stromal perspective.
Vickman RE; Faget DV; Beachy P; Beebe D; Bhowmick NA; Cukierman E; Deng WM; Granneman JG; Hildesheim J; Kalluri R; Lau KS; Lengyel E; Lundeberg J; Moscat J; Nelson PS; Pietras K; Politi K; Puré E; Scherz-Shouval R; Sherman MH; Tuveson D; Weeraratna AT; White RM; Wong MH; Woodhouse EC; Zheng Y; Hayward SW; Stewart SA
Oncotarget; 2020 Oct; 11(40):3621-3632. PubMed ID: 33088423
[TBL] [Abstract][Full Text] [Related]
7. Direct molecular dissection of tumor parenchyma from tumor stroma in tumor xenograft using mass spectrometry-based glycoproteomics.
Ye X; Luke BT; Wei BR; Kaczmarczyk JA; Loncarek J; Dwyer JE; Johann DJ; Saul RG; Nissley DV; McCormick F; Whiteley GR; Blonder J
Oncotarget; 2018 May; 9(41):26431-26452. PubMed ID: 29899869
[TBL] [Abstract][Full Text] [Related]
8. Retraction Note: MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinoma.
Fan Y; Xu LL; Shi CY; Wei W; Wang DS; Cai DF
Sci Rep; 2023 Dec; 13(1):21495. PubMed ID: 38057430
[No Abstract] [Full Text] [Related]
9. Revisiting stroma in pancreatic cancer.
Khan S; Jaggi M; Chauhan SC
Oncoscience; 2015; 2(10):819-20. PubMed ID: 26682261
[No Abstract] [Full Text] [Related]
10. Molecular Mechanisms of IL18 in Disease.
Yamanishi K; Hata M; Gamachi N; Watanabe Y; Yamanishi C; Okamura H; Matsunaga H
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139000
[TBL] [Abstract][Full Text] [Related]
11. The Role of IL-18 in P2RX7-Mediated Antitumor Immunity.
Janho Dit Hreich S; Hofman P; Vouret-Craviari V
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298187
[TBL] [Abstract][Full Text] [Related]
12. Tertiary lymphoid structures and their association to immune phenotypes and circulatory IL2 levels in pancreatic ductal adenocarcinoma.
Ahmed A; Köhler S; Klotz R; Giese N; Hackert T; Springfeld C; Zörnig I; Jäger D; Halama N
Oncoimmunology; 2022; 11(1):2027148. PubMed ID: 35127251
[TBL] [Abstract][Full Text] [Related]
13. Experimental microdissection enables functional harmonisation of pancreatic cancer subtypes.
Maurer C; Holmstrom SR; He J; Laise P; Su T; Ahmed A; Hibshoosh H; Chabot JA; Oberstein PE; Sepulveda AR; Genkinger JM; Zhang J; Iuga AC; Bansal M; Califano A; Olive KP
Gut; 2019 Jun; 68(6):1034-1043. PubMed ID: 30658994
[TBL] [Abstract][Full Text] [Related]
14. Stroma and pancreatic ductal adenocarcinoma: an interaction loop.
Luo G; Long J; Zhang B; Liu C; Xu J; Ni Q; Yu X
Biochim Biophys Acta; 2012 Aug; 1826(1):170-8. PubMed ID: 22521638
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma.
Diana A; Wang LM; D'Costa Z; Allen P; Azad A; Silva MA; Soonawalla Z; Liu S; McKenna WG; Muschel RJ; Fokas E
Oncotarget; 2016 Jul; 7(27):40992-41004. PubMed ID: 27329602
[TBL] [Abstract][Full Text] [Related]
16. Tumor-stroma interactions in pancreatic ductal adenocarcinoma.
Mahadevan D; Von Hoff DD
Mol Cancer Ther; 2007 Apr; 6(4):1186-97. PubMed ID: 17406031
[TBL] [Abstract][Full Text] [Related]
17. Immune features of the peritumoral stroma in pancreatic ductal adenocarcinoma.
Ahmed A; Klotz R; Köhler S; Giese N; Hackert T; Springfeld C; Jäger D; Halama N
Front Immunol; 2022; 13():947407. PubMed ID: 36131941
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
